- | Pays : -
- | Organes : -
- | Spécialités : -
Extrait
The objective of this study is to evaluate the effect of cabozantinib compared to prednisone on overall survival in men with previously treated metastatic castration-resistant prostate cancer with bone-dominant disease who have experienced disease progression on docetaxel-containing chemotherapy and abiraterone or MDV3100.
Critère d'inclusion
- Metastatic Castration-resistant Prostate Cancer (CRPC)